Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRVS Corvus Pharmaceuticals, Inc.

盘后交易 12-23 16:48:37 EST

4.55

-0.44

-8.82%

盘后4.62

+0.07+1.54%

16:48 EST

最高4.95	最低4.52	成交量128.40万
今开4.90	昨收4.99	日振幅8.54%
总市值2.92亿	流通市值1.90亿	总股本6,426万
成交额596.86万	换手率3.08%	流通股本4,172万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRVS","market":"US","secType":"STK","nameCN":"Corvus Pharmaceuticals, Inc.","latestPrice":4.55,"timestamp":1734987599999,"preClose":4.99,"halted":0,"volume":1284029,"hourTrading":{"tag":"盘后","latestPrice":4.62,"preClose":4.55,"latestTime":"16:48 EST","volume":14712,"amount":66945.528936,"timestamp":1734990505559},"delay":0,"floatShares":41722939,"shares":64257251,"eps":-1.01221,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.44,"latestTime":"12-23 16:48:37 EST","open":4.9,"high":4.946,"low":4.5201,"amount":5968577.2960713,"amplitude":0.085351,"askPrice":4.7,"askSize":2000,"bidPrice":4.55,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.01221,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"listingDate":1458705600000,"adjPreClose":4.99,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.98,"preClose":4.99,"latestTime":"09:28 EST","volume":7073,"amount":34437.323709799995,"timestamp":1734964080052},"postHourTrading":{"tag":"盘后","latestPrice":4.62,"preClose":4.55,"latestTime":"16:48 EST","volume":14712,"amount":66945.528936,"timestamp":1734990505559},"volumeRatio":0.296628,"impliedVol":1.3735,"impliedVolPercentile":0.5498},"requestUrl":"/m/hq/s/CRVS/tweets","defaultTab":"tweets","newsList":[{"id":"2493833764","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493833764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493833764?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:42","pubTimestamp":1734964949,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时42分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.73%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Rapt Therapeutics, Inc.较为活跃，换手率分别为698.90%、469.56%、127.18%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Gt Biopharma, Inc.、Rapt Therapeutics, Inc.，振幅分别为44.55%、44.13%、41.19%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322422995eadbdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322422995eadbdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2492715731","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492715731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492715731?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:43","pubTimestamp":1734619427,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时43分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.21%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.75%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Abpro Holdings Inc C/Wts 12/11/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Phio Pharmaceuticals Corp.、Psyence Biomedical Ltd.、Elevai Labs, Inc.较为活跃，换手率分别为421.50%、363.84%、355.39%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Mesoblast Ltd，振幅分别为92.86%、41.50%、39.17%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224353a1fb5c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224353a1fb5c20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2492548184","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘大幅跳水37.35%报4.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492548184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492548184?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:33","pubTimestamp":1734532437,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时33分，Corvus Pharmaceuticals, Inc.股票出现波动，股价大幅跳水37.35%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1029.28%、305.95%、241.70%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为66.83%、48.36%、38.10%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223408a1f8c28c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223408a1f8c28c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2492965542","title":"Corvus Pharmaceuticals, Inc.盘中异动 急速下挫6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965542?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:30","pubTimestamp":1734445824,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时30分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.52%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为1340.89%、90.51%、81.80%，振幅较大的相关个股有Mural Oncology Plc、Virpax Pharmaceuticals, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为5.81%、5.44%、3.77%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223024ab7f52a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223024ab7f52a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2491684690","title":"Corvus Pharmaceuticals, Inc.盘中异动 快速跳水5.25%报6.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491684690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491684690?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:03","pubTimestamp":1734361425,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时03分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.25%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216230345a1f3529f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216230345a1f3529f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2491305139","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491305139?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:41","pubTimestamp":1734111717,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时41分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.07%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214014157a1ec87a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214014157a1ec87a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2488407605","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.06%报8.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488407605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488407605?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:35","pubTimestamp":1733157312,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时35分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为2065.93%、1929.97%、254.54%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为481.02%、289.12%、64.17%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203003512abf03ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203003512abf03ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2485108914","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.16%报8.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485108914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485108914?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:19","pubTimestamp":1732209565,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时19分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.16%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Conduit Pharmaceuticals Inc.、Briacell Therapeutics Corp.、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为929.46%、508.29%、379.64%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011925a24bbe55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011925a24bbe55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2484913064","title":"Corvus Pharmaceuticals, Inc.2024财年第三财季实现净利润-40.22百万美元，同比减少570.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484913064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484913064?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010422,"startTime":"0","endTime":"0","summary":"11月19日，Corvus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-40.22百万美元，同比减少570.33%；其中营业收入为0.00美元，每股基本收益为-0.60美元。机构评级：截至2024年11月19日，当前有4家机构对Corvus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为15.75美元，其中最低目标价为12.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180048a2456218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180048a2456218&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS"],"gpt_icon":0},{"id":"2484674561","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674561?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:16","pubTimestamp":1731942999,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时16分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.01%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为555.61%、532.31%、340.66%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.81%、75.18%、73.24%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231639971a735c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231639971a735c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2483804359","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅下挫5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804359?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:39","pubTimestamp":1731595150,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时39分，Corvus Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.86%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1689.37%、24.08%、16.68%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pds Biotechnology Corporation，振幅分别为75.00%、38.46%、26.13%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422391098e42a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422391098e42a53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O：杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O：奥本海默将目标价从155美元上调至180美元  * ICU Medical Inc ICUI.O：Raymond James将目标价从190美元上调至205美元  * Kronos Bio Inc KRON.O：TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O：奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIT","BK4550","AROC","CAKE","BWXT","LU0234572021.USD","FDMT","SPRY","LU0868494708.USD","DOX","BPMC","CPB","CRVS","AMGN","LU1244550577.SGD","CHGG","AXTA","BK4209","ALMS","BRBR","BTMD","LU1894683348.USD","APD","CNNE","CPT","CPAY","APEI","AESI","AZTA","CHX","CTRA","ALSN","COGT","LU2106854487.HKD","ALLO","AVB","BIIB","CSCO","EE","LU1244550494.USD","IE00BZ1G4Q59.USD","BKR","IE00BFXG1179.USD","ADAP","ACRV","CBSH","SLRN","SG9999002232.USD","CAVA","LU0300736492.USD"],"gpt_icon":0},{"id":"2483988193","title":"Corvus Pharmaceuticals, Inc.股价拉升13.35% 市值涨8225.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483988193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483988193?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508368,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速上涨13.35%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.98%、177.69%、84.84%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Kairos Pharma, Ltd.、Lexeo Therapeutics, Inc.，振幅分别为14.89%、14.12%、11.27%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322324895be2394&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322324895be2394&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2482450952","title":"Corvus Pharmaceuticals Inc  预计每股亏损 11 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482450952","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482450952?lang=zh_cn&edition=full","pubTime":"2024-11-09 06:54","pubTimestamp":1731106450,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals Inc  预计每股亏损 11 美分 - 财报前瞻Corvus Pharmaceuticals Inc CRVS.OQ CRVS.O将于11月12日公布截至2024年9月30日的财报，预计季度营收将保持不变。LSEG分析师对Corvus Pharmaceuticals Inc的平均预期是每股亏损11美分。华尔街对 Corvus Pharmaceuticals Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 8.80 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF2XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVS"],"gpt_icon":0},{"id":"2480584284","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅下跌5.05%报8.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584284?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:47","pubTimestamp":1730731647,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时47分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、Kazia Therapeutics Limited涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为252.31%、160.30%、53.03%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为29.83%、25.56%、22.67%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224727a2155097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224727a2155097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2480818277","title":"Corvus Pharmaceuticals Inc    预计每股亏损 11 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480818277","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480818277?lang=zh_cn&edition=full","pubTime":"2024-11-02 12:06","pubTimestamp":1730520377,"startTime":"0","endTime":"0","summary":"   * Corvus Pharmaceuticals Inc    预计在11月5日公布截至2024年9月30日的财报时，季度收入将不会有任何变化()    *    * LSEG分析师对Corvus Pharmaceuticals Inc的平均预期是每股亏损11美分。* 华尔街对 Corvus Pharmaceuticals Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 9.10 美元。11月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Corvus Pharmaceuticals Inc    预计每股亏损 11 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVS"],"gpt_icon":0},{"id":"2478486442","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486442?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:36","pubTimestamp":1730122603,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时36分，Corvus Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.22%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Monte Rosa Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为548.96%、48.81%、36.99%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monopar Therapeutics Inc.、Calidi Biotherapeutics, Inc.，振幅分别为34.60%、18.55%、18.35%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213644971a2a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213644971a2a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2477132653","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477132653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477132653?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:41","pubTimestamp":1729780900,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时41分，Corvus Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.03%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Viking Therapeutics, Inc.、Biovie Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为232.01%、162.19%、90.33%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Chromocell Therapeutics Corporation，振幅分别为62.74%、60.32%、45.03%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024224140a1e75629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024224140a1e75629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2477352553","title":"BUZZ--美国股票走势-洛克希德马丁公司、通用汽车公司、菲利普莫里斯国际公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352553?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:53","pubTimestamp":1729612383,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月22日 - 周二美国股指下挫，原因是国债收益率上升影响了对利率敏感的行业，同时投资者通过评估收益来评估美国公司的健康状况。美东时间11:32，道琼斯工业平均指数  下跌0.2%，报42860.24点。标普500指数  下跌0.22%，报5840.9点；纳斯达克综合指数  下跌0.08%，报18524.375点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCO","PCAR","ZION","LMT","IPAR","WRB","MMM","FSLR","LEGN","GPC","ZETA","TQQQ","PTON","KMB","DHR","SGMO","IMUX","CRVS","QLD","NUE","MGRX","IPG",".IXIC","TXN","SHW","AOS","DDM","MNQmain","PII",".SPX","SQQQ","DJX","ASPN","PSQ","RTX","NSC","CDE","DGX","FCX","SDOW","CORZ","UDOW","CAKE","MRCC",".DJI","CSIQ"],"gpt_icon":1},{"id":"2477339619","title":"BUZZ--美国股票走势-3M、威瑞森通信、金佰利克拉克","url":"https://stock-news.laohu8.com/highlight/detail?id=2477339619","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477339619?lang=zh_cn&edition=full","pubTime":"2024-10-22 20:23","pubTimestamp":1729599818,"startTime":"0","endTime":"0","summary":"nL4N3LY0VV  ** Immunic Inc IMUX.O：盘前上涨18.1% BUZZ - 因多发性硬化症药物的中期后期数据而跳涨 nL4N3LY0XZ  ** Wolfspeed Inc WOLF.N：盘前下跌2.9% BUZZ - 因有报道称采埃孚退出德国芯片厂合作而下跌 nL4N3LY0YF (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nL4S3LY13S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHW","LU1861215975.USD","MLI","BK4585","ZETA","LU2237443978.SGD","SNSE","LU2211814178.USD","IE00BFMHRM44.USD","01548","GNPX","CRVS","SG9999001440.SGD","BK4568","VZ","MMM","IMUX","LU0130518102.USD","LMT","LCID","BK4515","LU0208291251.USD","LU0289739343.SGD","GPC","ENSC","MRCC","KMB","LU0006061336.USD","LU1621768206.USD","LU2355687059.USD","LU1066053197.SGD","LU0122379950.USD","IE00BMPRXN33.USD","DHR","PII","WOLF","GRI","LU0130103400.USD","LU1804176565.USD","LU0130102774.USD","AMN","LEGN","LU1791710582.SGD","HK0000306685.HKD","CDE","LU0130517989.USD","BK4190","HL","GM","BK4504"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.corvusbiotech.com","stockEarnings":[{"period":"1week","weight":-0.3238},{"period":"1month","weight":-0.3944},{"period":"3month","weight":-0.1557},{"period":"6month","weight":1.8034},{"period":"1year","weight":2.006},{"period":"ytd","weight":1.8352}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司，专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起，已建成四个免疫肿瘤的方案，其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品，CPI-444，A2A受体腺苷，免疫检查点的口服小分子拮抗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.025631},{"month":2,"riseRate":0.375,"avgChangeRate":-0.030453},{"month":3,"riseRate":0.375,"avgChangeRate":0.01862},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.096588},{"month":5,"riseRate":0.666667,"avgChangeRate":0.319834},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.075817},{"month":7,"riseRate":0.444444,"avgChangeRate":0.055809},{"month":8,"riseRate":0.666667,"avgChangeRate":0.121396},{"month":9,"riseRate":0.444444,"avgChangeRate":0.086364},{"month":10,"riseRate":0.333333,"avgChangeRate":0.009486},{"month":11,"riseRate":0.555556,"avgChangeRate":-0.010791},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.060184}],"exchange":"NASDAQ","name":"Corvus Pharmaceuticals, Inc.","nameEN":"Corvus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corvus Pharmaceuticals, Inc.,CRVS,Corvus Pharmaceuticals, Inc.股票,Corvus Pharmaceuticals, Inc.股票老虎,Corvus Pharmaceuticals, Inc.股票老虎国际,Corvus Pharmaceuticals, Inc.行情,Corvus Pharmaceuticals, Inc.股票行情,Corvus Pharmaceuticals, Inc.股价,Corvus Pharmaceuticals, Inc.股市,Corvus Pharmaceuticals, Inc.股票价格,Corvus Pharmaceuticals, Inc.股票交易,Corvus Pharmaceuticals, Inc.股票购买,Corvus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}